Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 3.55p
   
  • Change Today:
      0.000p
  • 52 Week High: 5.34
  • 52 Week Low: 1.60
  • Currency: UK Pounds
  • Shares Issued: 1,041.69m
  • Volume: 968,126
  • Market Cap: £36.98m
  • Beta: 0.02

Regulatory News

Result of AGM 22-May-2025 17:06 RNS
Audited results for the year ended 31 Dec 2024 24-Apr-2025 07:06 RNS
Licence Agreement in Japan for ACCRUFeR® 22-Apr-2025 07:01 RNS
Q1 2025 Trading Update 17-Apr-2025 11:23 RNS
ACCRUFeR® launched in Canada 11-Mar-2025 07:00 RNS
PDMR Transaction Notification 13-Feb-2025 16:15 RNS
Grant of Share Options 13-Feb-2025 07:00 RNS
Unaudited full year trading update 05-Feb-2025 07:00 RNS
Anders Lundstrom appointed CEO 27-Jan-2025 07:00 RNS
Result of General Meeting & Total Voting Rights 24-Dec-2024 11:25 RNS
Results of RetailBook Offer 23-Dec-2024 07:00 RNS
RetailBook Offer 06-Dec-2024 11:31 RNS
Subscription by AOP Health to raise US$10 million 06-Dec-2024 11:30 RNS
Business Update 21-Nov-2024 07:00 RNS
Q3 Trading Update 29-Oct-2024 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

STX Market Data

Currency UK Pounds
Share Price 3.55p
Change Today 0.000p
% Change 0.00 %
52 Week High 5.34
52 Week Low 1.60
Volume 968,126
Shares Issued 1,041.69m
Market Cap £36.98m
Beta 0.02

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
10.84% below the market average10.84% below the market average10.84% below the market average10.84% below the market average10.84% below the market average
69.57% above the sector average69.57% above the sector average69.57% above the sector average69.57% above the sector average69.57% above the sector average
Price Trend
49.65% above the market average49.65% above the market average49.65% above the market average49.65% above the market average49.65% above the market average
73.91% above the sector average73.91% above the sector average73.91% above the sector average73.91% above the sector average73.91% above the sector average
Income Not Available
Growth
63.08% above the market average63.08% above the market average63.08% above the market average63.08% above the market average63.08% above the market average
81.25% above the sector average81.25% above the sector average81.25% above the sector average81.25% above the sector average81.25% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 18-Jul-2025

Time Volume / Share Price
14:02 28,495 @ 3.44p
12:56 32,891 @ 3.45p
12:36 10,664 @ 3.59p
12:25 274 @ 3.41p
12:25 100,000 @ 3.59p

STX Key Personnel

CEO Anders Lundstrom

Top of Page